Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The International Papillomavirus Society proclaimed March 4th as “International HPV Awareness Day”.
Black and Latino men with HPV-associated throat cancer experience worse outcomes—including higher death rates—than white men.
A partnership to prevent human papillomavirus cancers maintained and even grew HPV vaccination rates for 9- to 13-year-olds.
Certain types of human papillomavirus cause almost all cases of cervical cancer.
A pilot program is assessing whether self-testing for the cancer-causing virus can reach women who otherwise might not get screened.
The Gardasil 9 vaccine protects against nine types of HPV.
Groups sign letter detailing urgent need to regain lost ground on prevention and early detection and to accelerate cancer research.
Data between 2005 and 2019 reveal the decline in cervical screenings—and the most common reasons women listed for not receiving them.
A look back at some of the most important science and treatment news Cancer Health covered this year.
Early vaccination reduces the risk of cervical cancer by nearly 90%, but many young people remain unprotected.
A majority people with oral and throat cancer tested positive for DNA from high-risk HPV types in their saliva.
Data from early clinical trials suggest new precision cancer treatments are on the horizon.
The antibody-drug conjugate Tivdak led to remission in 24% of cervical cancer patients.
Teens can receive the cancer-preventing HPV vaccine at the same time as their COVID-19 vaccine.
The vaccine protects against nine types of human papillomavirus, including those that cause cervical and anal cancer.
Prolonged delays in cancer screening for low-income women during the pandemic threaten to increase existing health disparities.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.